rxstat › Drug prices › Anifrolumab

Anifrolumab (Saphnelo) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Nov 16, 2026

Anifrolumab 150 mg/ml solution costs about $1722.64 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee.

Anifrolumab has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKNBNS
150 mg/ml Solution$1722.64/unit$5.74/unit$1722.64/vial$868.07/unit
120 mg/0.8ml Solution$430.66/unitnot covered–––
Plan coverageCoveredSpecial approvalSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 2 products
  • Saphnelo 120 mg/0.8ml Solution · AZC
    DIN 02566338 · $430.66/unit · Not covered
  • Saphnelo 150 mg/ml Solution · AZC
    DIN 02522845 · $1722.64/unit · Covered
Saskatchewan: 1 product
  • Saphnelo 150 mg/ml Solution · AST
    DIN 02522845 · $5.74/unit · Special approval
New Brunswick: 1 product
  • Saphnelo 150 mg/ml Solution · AZE
    DIN 02522845 · $1722.64/vial · Special approval
Nova Scotia: 1 product
  • Saphnelo 150 mg/ml Solution · AZE
    DIN 02522845 · $868.07/unit · Special approval

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

No shortage or discontinuation reports have been filed with Health Canada for Anifrolumab. rxstat watches those reports through the day; sign up below to hear if that changes.

Common questions

How much does Anifrolumab cost in Canada?

Anifrolumab 150 mg/ml solution costs about $1722.64 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee.

Is Anifrolumab covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.